Click play icon ▶️ to listen (transcript follows below): As a sought-after medical imaging industry thought leader, Mike Harsh sat for a recorded interview by
In accord with ASX requirements, Imagion Biosystems’ quarterly financial statement Appendix 4C was lodged with the Australian Securities Exchange on 31 July, 2017, accompanied by